| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
VistaGen Therapeutics Inc (NASDAQ: VTGN)
VTGN Technical Analysis
5
| As on 17th Dec 2025 VTGN SHARE Price closed @ 0.86 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.83 & Strong Sell for SHORT-TERM with Stoploss of 2.79 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VTGNSHARE Price
| Open | 0.88 | Change | Price | % |
| High | 0.97 | 1 Day | -3.50 | -80.28 |
| Low | 0.75 | 1 Week | -3.43 | -79.95 |
| Close | 0.86 | 1 Month | -3.21 | -78.87 |
| Volume | 72078539 | 1 Year | -1.98 | -69.72 |
| 52 Week High 4.90 | 52 Week Low 0.86 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| VYNE | 0.60 | 50.00% |
| NVDA | 170.94 | -3.81% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| IRBT | 0.76 | 0.00% |
| TSLA | 467.26 | -4.62% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VTGN Daily Charts |
VTGN Intraday Charts |
Whats New @ Bazaartrend |
VTGN Free Analysis |
|
|
VTGN Important Levels Intraday
| RESISTANCE | 1.28 |
| RESISTANCE | 1.15 |
| RESISTANCE | 1.06 |
| RESISTANCE | 0.98 |
| SUPPORT | 0.74 |
| SUPPORT | 0.66 |
| SUPPORT | 0.57 |
| SUPPORT | 0.44 |
VTGN Forecast December 2025
| 4th UP Forecast | 2.79 |
| 3rd UP Forecast | 2.17 |
| 2nd UP Forecast | 1.79 |
| 1st UP Forecast | 1.41 |
| 1st DOWN Forecast | 0.32 |
| 2nd DOWN Forecast | -0.07 |
| 3rd DOWN Forecast | -0.45 |
| 4th DOWN Forecast | -1.07 |
VTGN Weekly Forecast
| 4th UP Forecast | 1.48 |
| 3rd UP Forecast | 1.28 |
| 2nd UP Forecast | 1.16 |
| 1st UP Forecast | 1.03 |
| 1st DOWN Forecast | 0.69 |
| 2nd DOWN Forecast | 0.56 |
| 3rd DOWN Forecast | 0.44 |
| 4th DOWN Forecast | 0.24 |
VTGN Forecast2025
| 4th UP Forecast | 9.32 |
| 3rd UP Forecast | 6.61 |
| 2nd UP Forecast | 4.93 |
| 1st UP Forecast | 3.25 |
| 1st DOWN Forecast | -1.53 |
| 2nd DOWN Forecast | -3.21 |
| 3rd DOWN Forecast | -4.89 |
| 4th DOWN Forecast | -7.6 |
VistaGen Therapeutics Inc ( NASDAQ USA Symbol : VTGN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VTGN Business Profile
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in preparation for Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, panic, and others. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license and option agreements with Pherin Pharmaceuticals, Inc.; license and collaboration agreement with EverInsight Therapeutics Inc.; and license and sublicense agreement with BlueRock Therapeutics, LP. The company was founded in 1998 and is headquartered in South San Francisco, California. Address: 343 Allerton Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service